Timothy S. Ernst - 01 Sep 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: EVP, General Counsel & Sec
Issuer ticker: BIO
Reported as of: 01 Sep 2023
Net transaction value: -$377,632
SEC form: 4
Accepted by SEC: 06 Sep 2023, 13:06:34 UTC
Prior SEC filing: 31 Aug 2023
Next SEC filing: 29 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Timothy S. Ernst

Filing notes and source

Key filing fact

Timothy S. Ernst filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 06 Sep 2023.

Key facts

This page summarizes Timothy S. Ernst's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
16 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 06 Sep 2023, 13:06.

Change

Previous filing in this sequence was filed on 31 Aug 2023.
Current net transaction value: -$377,632.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +347
Change %: +14%
Price: $0.000000
Shares after: 2,763
Date: 01 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: -$68,266
Shares: -173
Change %: -6.3%
Price: $394.60
Shares after: 2,590
Date: 01 Sep 2023
Ownership: Direct

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +253
Change %: +9.8%
Price: $0.000000
Shares after: 2,843
Date: 01 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: -$49,720
Shares: -126
Change %: -4.4%
Price: $394.60
Shares after: 2,717
Date: 01 Sep 2023
Ownership: Direct

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +361
Change %: +13%
Price: $0.000000
Shares after: 3,078
Date: 02 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: -$70,633
Shares: -179
Change %: -5.8%
Price: $394.60
Shares after: 2,899
Date: 02 Sep 2023
Ownership: Direct

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +464
Change %: +16%
Price: $0.000000
Shares after: 3,363
Date: 03 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: -$91,153
Shares: -231
Change %: -6.9%
Price: $394.60
Shares after: 3,132
Date: 03 Sep 2023
Ownership: Direct

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +500
Change %: +16%
Price: $0.000000
Shares after: 3,632
Date: 04 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: -$97,861
Shares: -248
Change %: -6.8%
Price: $394.60
Shares after: 3,384
Date: 04 Sep 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +2,003
Change %
Price: $0.000000
Shares after: 2,003
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 2,003
Exercise price: $0.000000
Footnotes: F2, F3

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -347
Change %: -25%
Price: $0.000000
Shares after: 1,041
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 347
Exercise price: $0.000000
Footnotes: F2, F4

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -253
Change %: -33%
Price: $0.000000
Shares after: 507
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 253
Exercise price: $0.000000
Footnotes: F2, F5

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -361
Change %: -50%
Price: $0.000000
Shares after: 361
Date: 02 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 361
Exercise price: $0.000000
Footnotes: F2, F6

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -464
Change %: -50%
Price: $0.000000
Shares after: 464
Date: 03 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 464
Exercise price: $0.000000
Footnotes: F2, F7

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 500
Exercise price: $0.000000
Footnotes: F2, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F3

The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

Footnote F4

On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F5

On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F6

On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F7

On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Footnote F8

On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.